Increased Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Expression in the Conjunctival Epithelium Exposed to Antiglaucoma Treatments

References

• Asbell PA, Potapova N. Effects of topical antiglaucoma medications on the ocular surface. Ocul Surf 2005;3:27–40
   PubMed Web of Science ®Google Scholar
• Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol 1994;112:1437–1445
   PubMed Web of Science ®Google Scholar
• Schwab IR, Linberg JV, Gioia VM, Benson WH, Chao GM. Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications. Ophthalmology 1992;99:197–202
   PubMed Web of Science ®Google Scholar
• Baudouin C, Hamard P, Liang H, Creuzot-Garcher C, Benssoussan L, Brignole F. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmology 2004;111:2186–2192
   PubMed Web of Science ®Google Scholar
• Cvenkel B, Ihan A. Ocular surface changes induced by topical antiglaucoma monotherapy. Ophthalmologica 2002;216:175–179
   PubMed Web of Science ®Google Scholar
• Guglielminetti E, Barabino S, Monaco M, Mantero S, Rolando M. HLA-DR expression in conjunctival cells after latanoprost. J Ocul Pharmacol Ther 2002;18:1–9
   PubMedGoogle Scholar
• Bensoussan L, Blondin C, Baudouin C, Hamard P, Sabeh Afaki G, Creuzot-Garcher C, et al. [Flow cytometric analysis of HLA-DR, IL-6 and IL-8 expression by conjunctival epithelial cells from patients with prolonged topical antiglaucoma treatments]. J Fr Ophtalmol 2003;26:782–789
   PubMed Web of Science ®Google Scholar
• Rodrigues Mde L, Felipe Crosta DP, Soares CP, Deghalde NH, Duarte R, Sakamoto FS, et al. Immunohistochemical expression of HLA-DR in the conjunctiva of patients under topical prostaglandin analogs treatment. J Glaucoma 2009;18:197–200
   Google Scholar
• Broadway DC, Grierson I, O'Brien C, Hitchings RA. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 1994;112:1446–1454
   PubMed Web of Science ®Google Scholar
• Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 2010;29:312–334
   PubMed Web of Science ®Google Scholar
• Gabison EE, Mourah S, Steinfels E, Yan L, Hoang-Xuan T, Watsky MA, et al. Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio-stromal interactions and matrix metalloproteinase induction. Am J Pathol 2005;166:209–219
   PubMed Web of Science ®Google Scholar
• Wong TT, Sethi C, Daniels JT, Limb GA, Murphy G, Khaw PT. Matrix metalloproteinases in disease and repair processes in the anterior segment. Surv Ophthalmol 2002;47:239–256
   PubMed Web of Science ®Google Scholar
• Shapiro SD. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 1998;10:602–608
   PubMed Web of Science ®Google Scholar
• Huet E, Gabison EE, Mourah S, Menashi S. Role of emmprin/CD147 in tissue remodeling. Connect Tissue Res 2008;49:175–179
   PubMed Web of Science ®Google Scholar
• Maatta M, Tervahartiala T, Kaarniranta K, Tang Y, Yan L, Tuukkanen J, et al. Immunolocalization of EMMPRIN (CD147) in the human eye and detection of soluble form of EMMPRIN in ocular fluids. Curr Eye Res 2006;31:917–924
   Web of Science ®Google Scholar
• Huet E, Vallee B, Delbe J, Mourah S, Prulière-Escabasse V, Tremouilleres M, et al. EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye disease. Am J Pathol 2011;179:1278–1286
   Google Scholar
• Baudouin C, Liang H, Hamard P, Riancho L, Creuzot-Garcher C, Warnet JM, et al. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology 2008;115:109–115
   PubMed Web of Science ®Google Scholar
• Brignole-Baudouin F, Ott AC, Warnet JM, Baudouin C. Flow cytometry in conjunctival impression cytology: a new tool for exploring ocular surface pathologies. Exp Eye Res 2004;78:473–481
   PubMed Web of Science ®Google Scholar
• Baudouin C, Liang H, Bremond-Gignac D, Hamard P, Hreiche R, Creuzot-Garcher C, et al. CCR 4 and CCR 5 expression in conjunctival specimens as differential markers of T(H)1/T(H)2 in ocular surface disorders. J Allergy Clin Immunol 2005;116:614–619
   Google Scholar
• Brasnu E, Brignole-Baudouin F, Riancho L, Warnet JM, Baudouin C. Comparative study on the cytotoxic effects of benzalkonium chloride on the Wong-Kilbourne derivative of Chang conjunctival and IOBA-NHC cell lines. Mol Vis 2008;14:394–402
   Google Scholar
• Gabison EE, Huet E, Baudouin C, Menashi S. Direct epithelial-stromal interaction in corneal wound healing: role of EMMPRIN/CD147 in MMPs induction and beyond. Prog Retin Eye Res 2009;28:19–33
   PubMed Web of Science ®Google Scholar
• Leng F, Liu P, Li H, Zhang J. Long-term topical antiglaucoma medications cause enhanced Tenon's capsule fibroblast proliferation and abnormal TGF-beta and MMP expressions: potential effects on glaucoma filtering surgery. Curr Eye Res 2011;36:301–309
   PubMed Web of Science ®Google Scholar
• Lopilly Park HY, Kim JH, Lee KM, Park CK. Effect of prostaglandin analogues on tear proteomics and expression of cytokines and matrix metalloproteinases in the conjunctiva and cornea. Exp Eye Res 2012;94:13–21
   PubMed Web of Science ®Google Scholar
• Honda N, Miyai T, Nejima R, Miyata K, Mimura T, Usui T, et al. Effect of latanoprost on the expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase 1 on the ocular surface. Arch Ophthalmol 2010;128:466–471
   PubMedGoogle Scholar
• Terai N, Schlotzer-Schrehardt U, Lampel J, Böhm AG, Rummelt C, Schmidt E, et al. Effect of latanoprost and timolol on the histopathology of the human conjunctiva. Br J Ophthalmol 2009;93:219–224
   Google Scholar
• Di Girolamo N, Lloyd A, McCluskey P, Filipic M, Wakefield D. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol 1997;150:653–666
   PubMed Web of Science ®Google Scholar
• Azar DT, Pluznik D, Jain S, Khoury JM. Gelatinase B and A expression after laser in situ keratomileusis and photorefractive keratectomy. Arch Ophthalmol 1998;116:1206–1208
   Google Scholar
• Wong TT, Mead AL, Khaw PT. Matrix metalloproteinase inhibition modulates postoperative scarring after experimental glaucoma filtration surgery. Invest Ophthalmol Vis Sci 2003;44:1097–1103
   PubMed Web of Science ®Google Scholar
• Wong TT, Mead AL, Khaw PT. Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery. Invest Ophthalmol Vis Sci 2005;46:2018–2022
   PubMed Web of Science ®Google Scholar
• Ito T, Ohguro H, Mamiya K, Ohguro I, Nakazawa M. Effects of antiglaucoma drops on MMP and TIMP balance in conjunctival and subconjunctival tissue. Invest Ophthalmol Vis Sci 2006;47:823–830
   PubMed Web of Science ®Google Scholar
• Labbe A, Terry O, Brasnu E, Van Went C, Baudouin C. Tear film osmolarity in patients treated for glaucoma or ocular hypertension. Cornea 2012;31:994–999
   PubMed Web of Science ®Google Scholar
• Khaw PT, Occleston NL, Schultz G, Gierson I, Sherwood MB, Larkin G. Activation and suppression of fibroblast function. Eye (Lond) 1994;8:188–195
   PubMed Web of Science ®Google Scholar
• Girard MT, Matsubara M, Fini ME. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci 1991;32:2441–2454
   PubMed Web of Science ®Google Scholar
• Epstein SP, Chen D, Asbell PA. Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells. J Ocul Pharmacol Ther 2009;25:415–424
   PubMed Web of Science ®Google Scholar
• Yurchenko V, Pushkarsky T, Li JH, Dai WW, Sherry B, Bukrinsky M. Regulation of CD147 cell surface expression: involvement of the proline residue in the CD147 transmembrane domain. J Biol Chem 2005;280:17013–17019
   Google Scholar
• Pushkarsky T, Yurchenko V, Vanpouille C, Brichacek B, Vaisman I, Hatakeyama S, et al. Cell surface expression of CD147/EMMPRIN is regulated by cyclophilin 60. J Biol Chem 2005;280:27866–27871
   PubMed Web of Science ®Google Scholar
• Gabison EE, Hoang-Xuan T, Mauviel A, Menashi S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 2005;87:361–368
   PubMed Web of Science ®Google Scholar
• Cristofanilli M, Pescosolido N, Risuleo G, Scarsella G. A murine cell culture model for post-trabeculectomy anfibrotic treatment: induction of apoptosis by cyclosporin. Acta Ophthalmol Scand 2001;79:309–312
   Google Scholar
• Turacli E, Gunduz K, Aktan G, Tamer C. A comparative clinical trial of mitomycin C and cyclosporin A in trabeculectomy. Eur J Ophthalmol 1996;6:398–401
   Google Scholar